Literature DB >> 14717752

Treatment of breast cancer in medically underserved women: a review.

Lisa C Richardson1.   

Abstract

Women at risk of being undertreated for breast cancer include women who are older, from minority groups, from lower socioeconomic backgrounds, and those without health insurance or insured by Medicaid. Recent reviews of the cancer care experience of medically underserved populations indicate that breast cancer care may be even less optimal for these populations than the majority of women. These are the same women who may experience difficulty obtaining access to medical care once they are diagnosed with breast cancer. Indirect proof of problems with access is manifested as higher recurrence rates of breast cancer and differences in breast cancer-specific survival among medically underserved women. Multiple factors have been shown to affect access to medical care, and therefore quality of care, including patient-level factors, provider-level factors, and health system factors. This article reviews the current state of these factors in explaining breast cancer care in medically underserved women.

Entities:  

Mesh:

Year:  2004        PMID: 14717752     DOI: 10.1111/j.1524-4741.2004.09511.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  7 in total

1.  Prognostic influence of Korean public medical insurance system on breast cancer patients.

Authors:  Ki-Tae Hwang; Young Wook Ju; Young A Kim; Jongjin Kim; Sohee Oh; Jiwoong Jung; Young Jun Chai; In Sil Choi; So Won Oh
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

2.  Cancer support and resource needs among African American older adults

Authors:  Jennifer Wenzel; Randy A Jones; Rachel Klimmek; Sharon Krumm; Linda P Darrell; Danny Song; Vered Stearns; Jean G Ford
Journal:  Clin J Oncol Nurs       Date:  2012-08       Impact factor: 1.027

3.  What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.

Authors:  Marie-Anne Durand; Renata West Yen; A James O'Malley; Mary C Politi; Shubhada Dhage; Kari Rosenkranz; Katie Weichman; Julie Margenthaler; Anna N A Tosteson; Eloise Crayton; Sherrill Jackson; Ann Bradley; Robert J Volk; Karen Sepucha; Elissa Ozanne; Sanja Percac-Lima; Julia Song; Jocelyn Acosta; Nageen Mir; Glyn Elwyn
Journal:  BMC Public Health       Date:  2018-02-13       Impact factor: 3.295

4.  Adapting the Breast Cancer Surgery Decision Quality Instrument for Lower Socioeconomic Status: Improving Readability, Acceptability, and Relevance.

Authors:  Marie-Anne Durand; Julia Song; Renata West Yen; Karen Sepucha; Mary C Politi; Shubhada Dhage; Kari Rosenkranz; Julie Margenthaler; Anna N A Tosteson; Eloise Crayton; Sherrill Jackson; Ann Bradley; A James O'Malley; Robert J Volk; Elissa Ozanne; Sanja Percac-Lima; Jocelyn Acosta; Nageen Mir; Peter Scalia; Abigail Ward; Glyn Elwyn
Journal:  MDM Policy Pract       Date:  2018-11-25

5.  End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer.

Authors:  Siran M Koroukian; Heather Beaird; Elizabeth Madigan; Mireya Diaz
Journal:  Health Care Financ Rev       Date:  2006

6.  Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors.

Authors:  Paolo Giorgi Rossi; Olivera Djuric; Simone Navarra; Alessandra Rossi; Anteo Di Napoli; Luisa Frova; Alessio Petrelli
Journal:  Int J Environ Res Public Health       Date:  2020-06-11       Impact factor: 3.390

7.  What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.

Authors:  Marie-Anne Durand; Renata W Yen; A James O'Malley; Danielle Schubbe; Mary C Politi; Catherine H Saunders; Shubhada Dhage; Kari Rosenkranz; Julie Margenthaler; Anna N A Tosteson; Eloise Crayton; Sherrill Jackson; Ann Bradley; Linda Walling; Christine M Marx; Robert J Volk; Karen Sepucha; Elissa Ozanne; Sanja Percac-Lima; Emily Bergin; Courtney Goodwin; Caity Miller; Camille Harris; Richard J Barth; Rebecca Aft; Sheldon Feldman; Amy E Cyr; Christina V Angeles; Shuai Jiang; Glyn Elwyn
Journal:  Cancer       Date:  2020-11-10       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.